SCHEMBL4966480

SCHEMBL4966480

O=C1[N]c2c(cc(Cc3ccccc3)cc2N2CCNCC2)N1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.46
HTR6 P50406 8/20 0.43
ITGA2B P08514 1/20 0.40
DPP4 P27487 1/20 0.40
HTR1A P08908 3/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
NCF1 P14598 2/20 0.39
HTR2C P28335 1/20 0.38
KDR P35968 1/20 0.37
CETP P11597 1/20 0.37
HTR3A P46098 1/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
HTR2A P28223 1/20 0.36
HTR7 P34969 1/20 0.36
HTR5A P47898 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4967183 0.91 HTR2C (0.46) TAAR1HTR6DPP4HTR1ASLC6A2
SCHEMBL4963734 0.77 ADRB1 (0.38) HTR6HTR1ANCF1KDRHTR3A
SCHEMBL4963979 0.74 IDH1 (0.44)
SCHEMBL4964772 0.74 HRH1 (0.51)
SCHEMBL4966050 0.72 GABRA1 (0.38) HTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL4964869 0.71 SLC6A4 (0.41) HTR6HTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL4964731 0.68 KIT (0.42) SLC6A2SLC6A4SLC6A3
SCHEMBL4966731 0.68 TAAR1 (0.41) TAAR1HTR6HTR1AHTR2A
Hydrochloric Acid SCHEMBL4964910 0.68 KIT (0.39) SLC6A4
SCHEMBL6164646 0.66 HTR1A (0.60) TAAR1HTR6HTR1ASLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904483-A1 BENZIMIDAZOLE DERIVATIVES AS 5-HT6,5-HT24 F. Hoffmann-Roche AG (CH) 2008-04-02 EP claimed
WO-2007006677-A1 BENZIMIDAZOLE DERIVATIVES AS 5-HT6,5-HT24 F. HOFFMANN-LA ROCHE AG (CH) 2007-01-18 WO claimed